Latest papers

Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.

[Biomarkers of endocrine therapy-resistance in breast cancers].

Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.

Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.

Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.

Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors.

A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.

The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.

Analysis of demographic and tumor characteristics of an inner city breast cancer patient population compared with patients treated in National Surgical Adjuvant Breast and Bowel Project trials.

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.

Effects of anti-EGFR antibody cetuximab on androgen-independent prostate cancer cells.

Antidepressants and tamoxifen. Drug interactions may increase risk of cancer recurrence or death.

Triple-negative breast cancer: correlation between imaging and pathological findings.

The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.

Positive progesterone receptors and cell proliferation index: an independent association with breast cancer in males.

Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study.

Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: A pathological and immunohistochemical study

MicroRNAs and prostate cancer.

Frequency of Screening Magnetic Resonance Imaging to Detect Occult Spinal Cord Compromise and to Prevent Neurological Deficit in Metastatic Castration-resistant Prostate Cancer